AAAAAA

   
Results: 1-19 |
Results: 19

Authors: Atencio, DP Iannuzzi, CM Green, S Stock, RG Bernstein, JL Rosenstein, BS
Citation: Dp. Atencio et al., Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high-performance liquid chromatography, ENV MOL MUT, 38(2-3), 2001, pp. 200-208

Authors: Nag, S Ciezki, JP Cormack, R Doggett, S DeWyngaert, K Edmundson, GK Stock, RG Stone, NN Yu, Y Zelefsky, MJ
Citation: S. Nag et al., Intraoperative planning and evaluation of permanent prostate brachytherapy: Report of the American Brachytherapy Society, INT J RAD O, 51(5), 2001, pp. 1422-1430

Authors: Snyder, KM Stock, RG Hong, SM Lo, YC Stone, NN
Citation: Km. Snyder et al., Defining the risk of developing grade 2 proctitis following I-125 prostatebrachytherapy using a rectal dose-volume histogram analysis, INT J RAD O, 50(2), 2001, pp. 335-341

Authors: Stock, RG Kao, J Stone, NN
Citation: Rg. Stock et al., Penile erectile function after permanent radioactive seed implantation fortreatment of prostate cancer, J UROL, 165(2), 2001, pp. 436-439

Authors: Stone, NN Stock, RG Unger, P
Citation: Nn. Stone et al., Effects of neoadjuvant hormonal therapy on prostate biopsy results after I-125 and Pd-103 seed implantation, MOL UROL, 4(3), 2000, pp. 163-168

Authors: Stone, NN Stock, RG Unger, P Kao, J
Citation: Nn. Stone et al., Biopsy results after real-time ultrasound-guided transperineal implants for stage T-1-T-2 prostate cancer, J ENDOUROL, 14(4), 2000, pp. 375-380

Authors: Stock, RG Stone, NN Lo, YC Malhado, N Kao, J DeWyngaert, JK
Citation: Rg. Stock et al., Postimplant dosimetry for I-125 prostate implants: Definitions and factorsaffecting outcome, INT J RAD O, 48(3), 2000, pp. 899-906

Authors: Stone, NN Stock, RG
Citation: Nn. Stone et Rg. Stock, Prostate brachytherapy in patients with prostate volumes >= 50 cm(3): Dosimetic analysis of implant quality, INT J RAD O, 46(5), 2000, pp. 1199-1204

Authors: Lehrer, S McCurdy, LD Stock, RG Kornreich, R Stone, NN Eng, C
Citation: S. Lehrer et al., Body mass, age, and the APC I1307K allele in Ashkenazi Jewish prostate cancer patients, CANC GENET, 122(2), 2000, pp. 131-133

Authors: Stock, RG Stone, NN Kao, J Iannuzzi, C Unger, P
Citation: Rg. Stock et al., The effect of disease and treatment-related factors on biopsy results after prostate brachytherapy - Implications for treatment optimization, CANCER, 89(8), 2000, pp. 1829-1834

Authors: Stone, NN Stock, RG
Citation: Nn. Stone et Rg. Stock, Neoadjuvant hormonal therapy improves the outcomes of patients undergoing radioactive seed implantation for localized prostate cancer, MOL UROL, 3(3), 1999, pp. 239-244

Authors: Iannuzzi, CM Stock, RG Stone, NN
Citation: Cm. Iannuzzi et al., PSA kinetics following I-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer, RADIAT ON I, 7(1), 1999, pp. 30-35

Authors: Stock, RG Stone, NN
Citation: Rg. Stock et Nn. Stone, Permanent radioactive seed implantation in the treatment of prostate cancer, HEMAT ONCOL, 13(3), 1999, pp. 489

Authors: Stock, RG Lo, YC Gaildon, M Stone, NN
Citation: Rg. Stock et al., Does prostate brachytherapy treat the seminal vesicles? A dose-volume histogram analysis of seminal vesicles in patients undergoing combined Pd-103 prostate implantation and external beam irradiation, INT J RAD O, 45(2), 1999, pp. 385-389

Authors: Green, S Stock, RG Greenstein, AJ
Citation: S. Green et al., Rectal cancer and inflammatory bowel disease: Natural history and implications for radiation therapy, INT J RAD O, 44(4), 1999, pp. 835-840

Authors: Stone, NN Stock, RG
Citation: Nn. Stone et Rg. Stock, Laparoscopic pelvic lymph node dissection in the staging of prostate cancer, MT SINAI J, 66(1), 1999, pp. 26-30

Authors: Stone, NN Stock, RG
Citation: Nn. Stone et Rg. Stock, Prostate brachytherapy: Treatment strategies, J UROL, 162(2), 1999, pp. 421-426

Authors: Stock, RG Stone, NN Yeghiayan, P
Citation: Rg. Stock et al., Neoadjuvant androgen suppression and permanent radioactive seed implantation in the treatment of stage T-1-T-2 prostate cancer, MOL UROL, 2(3), 1998, pp. 121-126

Authors: Garnick, MB Stock, RG Roach, M
Citation: Mb. Garnick et al., Neoadjuvant androgen suppression and permanent radioactive seed implantation in the treatment of stage T-1-T-2 prostate cancer - Discussion, MOL UROL, 2(3), 1998, pp. 127-127
Risultati: 1-19 |